ArticleSignal transduction and targeted therapy2022

OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor.

Chuannan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.